Ruth Adams
Director Técnico/Científico/I+D en NUVALENT, INC. .
Cargos activos de Ruth Adams
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NUVALENT, INC. | Director Técnico/Científico/I+D | 01/11/2020 | - |
Historial de carrera de Ruth Adams
Antiguos cargos conocidos de Ruth Adams.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Vigeo Therapeutics, Inc.
 Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | - | - |
Formación de Ruth Adams.
| The University of Southampton | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Reino Unido | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NUVALENT, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Vigeo Therapeutics, Inc.
Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Ruth Adams
- Experiencia
